Combination drug therapy shrinks breast cancer tumor
Drug duo may help fight breast cancer
New Technology Changes How Women Are Screened For Breast Cancer
Posted: 01/17/2012
Good news in the fight against breast cancer. A study published in "The Lancet Oncology" finds that when two cancer drugs join forces they significantly reduce tumor size.
Women with "Her-2 Positive" breast cancer were treated with a combination of both drugs. After six weeks, those patients had tumors 22 percent smaller than women taking either drug alone.
Herceptin is already approved for breast cancer. Tykerb has only been used for treatment of advanced cancer. This is the first time they have been tested together.
Copyright 2012 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
PRINT
Health
-
FDA warns teens against tanning beds
If you're hoping to get a jump start on your tan this summer, the Food and Drug Administration has a warning for you.
-
Foods that make your skin glow
Want your skin to look great for the summer?
There are a few things you can do between now and then to improve your glow.
-
Preemies get a boost from music
A rock song says music can soothe the soul but hospitals are finding it can help premature infants and other sick babies, too.
- Stay Connected
